RARA and acute myeloid leukemia: FTO, as an oncogenic protein, participates in promoting AML cell proliferation and transformation while hindering AML cell differentiation and apoptosis, especially in AML subtypes with MLL-rearrangements and PML-RARA, FLT3-ITD and NPM1 mutations.